Draft:Levy Review

The Levy Review is an ongoing independent review of NHS Gender Dysphoria Clinics (GDCs) in England, led by Dr David Levy and commissioned by NHS England. The review examines the operation, delivery, safety, effectiveness and patient experience of adult GDCs, and will inform an updated non-surgical service specification and related policy.

Background

[edit]

The review follows the Cass Review, another independent review which examined paediatric gender services and identified gaps in the evidence base and concerns about pathways between child and adult services. NHS England said concerns raised during and after the Cass Review, including about data, clinical governance, assessment processes and waiting times, indicated that adult services also required independent scrutiny.

Scope

[edit]

In November 2024, NHS England published terms of reference, stating that the independent review will assess whether the operation and delivery of adult Gender Dysphoria Clinics (GDCs) meet the requirements of the current non-surgical service specification, and will examine safety, effectiveness, clinical governance and patient experience across services. The review’s workstreams include clinic visits and inspections, stakeholder engagement, including surveys of patients, families and staff, review of the evidence base for hormone therapies, and contribution to an updated non-surgical service specification and to national policy on masculinising and feminising hormones.

History

[edit]

NHS England appointed Dr David Levy to lead the review in mid-2024. Media reporting of the appointment appeared in August 2024. NHS England indicated that the review team would begin on-site visits to clinics in September 2024 and would carry out engagement with patients, staff, and professional bodies as part of its assessment. In December 2024, the review launched stakeholder engagement activity, including a survey, to gather patient and staff experiences and evidence. Organisations such as the Gender Identity Research and Education Society (GIRES) publicised the engagement and summarised opportunities for involvement in early 2025.

Reactions and commentary

[edit]

The announcement and early stages of the review prompted varied responses. Some commentators and Members of Parliament described the review as a necessary follow-up to the Cass Review and part of wider policy work on gender identity services, citing concerns about the evidence base, clinical governance and prolonged waiting times. LGBTQ+ charities and advocacy groups expressed concern about potential harms to trans patients and emphasised the need for transparent, evidence-based processes and meaningful patient involvement, while other commentators highlighted gaps in evidence and called for improved data sharing and research.

References

[edit]
[edit]